Todd C. Brady - Feb 28, 2023 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role: President and CEO, Director
Signature: /s/ Todd C. Brady
Stock symbol: ALDX
Transactions as of: Feb 28, 2023
Transactions value $: $0
Form type: 4
Date filed: 3/2/2023, 03:22 PM
Previous filing: Jul 19, 2022
Next filing: May 11, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALDX	Common Stock	Award	$0	+239K	+19.63%	$0.00	1.46M	Feb 28, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALDX	Stock Option (right to buy)	Award	$0	+250K		$0.00	250K	Feb 28, 2023	Common Stock	250K	$6.76	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2023, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
F2	The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2023.